Neil Osheroff Archives
Novel drugs have potential for treating tuberculosis
Apr. 24, 2023—Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.
Study explores new urinary tract infection treatment
Feb. 2, 2023—Vanderbilt's Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.
Capacity building activities and new curriculum strengthen medical education in Liberia
Feb. 24, 2022—Liberia's fragile health system is being strengthened through U.S.-Liberia partnerships focused on medical education and capacity building at the country's only medical school, A.M. Dogliotti (AMD) School of Medicine in the College of Health Sciences at the University of Liberia.
Osheroff elected to AAMC council leadership post
Jul. 22, 2021—Neil Osheroff, PhD, professor of Biochemistry and Medicine, has been elected to a leadership position for a council of the Association of American Medical Colleges (AAMC).
Osheroff elected IAMSE president
Dec. 12, 2019—Neil Osheroff, PhD, was elected president of the International Association of Medical Science Educators (IAMSE) and will serve from January 2020-December 2021.
International Association of Medical Science Educators honors Osheroff
Jul. 8, 2019—Neil Osheroff, PhD, John G. Coniglio professor of Biochemistry, professor of Medicine and director of the Academy for Excellence in Education, received the Distinguished Career Award for Excellence in Teaching and Educational Scholarship from the International Association of Medical Science Educators (IAMSE).
A new antibiotic’s mechanism of action
Apr. 25, 2019—Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.
Correctly copying DNA
Mar. 14, 2019—A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.
Five faculty elected AAAS fellows
Nov. 29, 2018—Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
Confronting TB resistance
Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
Self care, mindfulness key to decreasing burnout: speaker
Apr. 26, 2018—It’s not often that a keynote speaker will ask his audience to close their eyes and tune him out, but that’s what Aviad “Adi” Haramati, PhD, did when delivering the 2018 John E. Chapman Lecture.
Novel insights to antibiotic targets
Sep. 29, 2017—New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.
